Patient Support Services

At Genzyme, we believe in more than just developing therapies. We're committed to helping patients who need our treatments obtain access to them – regardless of their ability to pay.
U.S. Patient Support

Because many of the conditions that Genzyme's therapies treat are rare, our patients often face challenges with insurers that are unfamiliar with these diseases and their therapies. Moreover, with the variety of health plans found in the United States, many people encounter restrictions in their coverage – or have no medical coverage at all. Genzyme has long been an industry leader in developing patient support services and programs that provide such assistance as:

  • Helping patients navigate the complexities of their insurance plans (both private and public)
  • Researching alternative forms of funding and reimbursement
  • Providing free or subsidized treatment for those patients with no other options
  • Access to educational resources and programs for patients to learn more about their disease and treatment

We were one of the first major pharmaceutical or biotech companies to assign individual case managers who work one-on-one with patients in the U.S. to help obtain ongoing access to treatment, especially for those with rare lysosomal storage disorders that require lifelong enzyme replacement therapies. Committed to maintaining this level of service, we continue to closely monitor the health care environment to understand how changes in public policy, the private insurance market, and other areas may affect patients.

Click a product name to learn about the support options that Genzyme offers patients and their families in the U.S.

View All
Global Efforts

Outside the United States, medical care is often managed and funded by national governments. In such countries, Genzyme works closely with governments to help facilitate approval of our treatments and ensure that they are accessible to citizens covered by national health services.

In developing countries, we help physicians and local authorities build sustainable health care systems that can pay for critical treatment. Where such systems do not yet exist, we provide free treatment to patients in the interim until longer-term, sustainable solutions can be established locally.

If you live outside the U.S. and need assistance getting or paying for treatment, talk to your health care providers or a local patient organization. You can also contact Genzyme in your region.

Patient Access to Treatment

Learn more about Genzyme's efforts in:

Last Updated: 3/12/2015
Contact Us
Genzyme Medical Information
U.S. and Canada

T: 800-745-4447 (toll-free)
T: 617-768-9000

Send Email
Reporting Side Effects
Monitoring Product Safety

Help Genzyme assess the ongoing safety of our treatments by reporting any suspected side effects.

Facing Fabry Together

Through powerful testimonials from patients, caregivers, and health care professionals, this film shares the stories of four families from around the world that are living with Fabry disease.

Spirit: Live a Better Life with MS

Genzyme has developed a 7-week online program for people living with MS in Norway, Denmark, Sweden, and Finland. The program is based on the newest research within health and positive psychology and focuses on inner personal strength.

Visit the sites (all programs are in local languages):